Column Group LLC Long-Term Concentrated

CIK: 0001833486 · Show all filings

Period: Q4 2023 (← Previous) (Next →)

Filing Date: Feb 9, 2024

Total Value ($000): $151,378 (100.0% shares, 0.0% debt)

Holdings (6)

— RAPT Therapeutics Inc 44.0%

Value ($000) $66,613 Shares 2,680,621 Est. Cost $19.03 Unrealized —

ORIC ORIC Pharmaceuticals Inc. 21.7%

Value ($000) $32,827 Shares 3,568,181 Est. Cost $28.69 Unrealized -74.8%

TNYA Tenaya Therapeutics, Inc. 20.1%

Value ($000) $30,457 Shares 9,400,290 Est. Cost $21.49 Unrealized -90.0%

— NGM Biopharmaceuticals Inc 10.3%

Value ($000) $15,579 Shares 18,136,735 Est. Cost $27.77 Unrealized —

— Surrozen, Inc. 3.9%

Value ($000) $5,900 Shares 627,651 Est. Cost $6.84 Unrealized —

RVMD Revolution Medicines Inc 0.0%

Value ($000) $1 Shares 46 Est. Cost $34.24 Unrealized -29.8%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	RAPT Therapeutics Inc	2,680,621	$66,613	44.0%	$19.03	—	COM	75382E109
ORIC	ORIC Pharmaceuticals Inc.	3,568,181	$32,827	21.7%	$28.69	-74.8%	COM	68622P109
TNYA	Tenaya Therapeutics, Inc.	9,400,290	$30,457	20.1%	$21.49	-90.0%	COM	87990A106
—	NGM Biopharmaceuticals Inc	18,136,735	$15,579	10.3%	$27.77	—	COM	62921N105
—	Surrozen, Inc.	627,651	$5,900	3.9%	$6.84	—	COM	86889P109
RVMD	Revolution Medicines Inc	46	$1	0.0%	$34.24	-29.8%	COM	76155X100